REQUEST A DEMO
Total
USD $0.00
Search more companies

Komipharm International Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Komipharm International Co.,Ltd. Profile Updated: August 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Komipharm International Co.,Ltd. is engaged in manufacturing of veterinary biological vaccines, veterinary pharmaceuticals products including medicine, disinfectant as well as Bio-fertilizer. The company also offers services including clinical pathological experiment, test and analysis. Komipharm International Co.,Ltd. also distribute its products in Europe, Asia and Africa. The company is based in Siheung, Gyeonggi-do Province, South Korea. Komipharm International Co.,Ltd. was incorporated in 1972 formerly known as Korea Microbiological Lab., Ltd.

Headquarters
107 Shihwa Gongdan 1-Ra, Jungwang-Dong, Sihung-Si
Siheung; Gyeonggi; Postal Code: 429-450

Contact Details: Purchase the Komipharm International Co.,Ltd. report to view the information.

Website: http://www.komipharm.com

Basic Information
Total Employees:
Purchase the Komipharm International Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Komipharm International Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Komipharm International Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Komipharm International Co.,Ltd. report to view the information.
Incorporation Date:
September 21, 1972
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
33.56%
Purchase this report to view the information.
7.26%
Purchase this report to view the information.
2.22%
Purchase this report to view the information.
0.6%
Purchase this report to view the information.
0.3%
Subsidiaries
Komipharm International America Inc
Komipharm International Australia Pty Ltd
Company Performance
Financial values in the chart are available after Komipharm International Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
22.07%
Total operating revenue
20.54%
Operating profit (EBIT)
-26.48%
EBITDA
-17.75%
Net Profit (Loss) for the Period
-31.35%
Total assets
8.28%
Total equity
-17.7%
Operating Profit Margin (ROS)
-0.48%
Net Profit Margin
-1.03%
Return on Equity (ROE)
-2.75%
Debt to Equity Ratio
40.19%
Quick Ratio
-0.19%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?